News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cognoptix President And CEO Paul Hartung Tells Analysts: “Our Vision Is To Change The Course Of Alzheimer’s Disease By Enabling Early Diagnosis At The Point Of Care.”


4/2/2014 7:42:27 AM

Killybegs isn't the only one hiring, others are hiring too! Check it out! (Isn't it tempting?)

ACTON, Mass.--(BUSINESS WIRE)--Cognoptix President and CEO Paul Hartung told a group of analysts yesterday: “Our vision is to change the course of Alzheimer’s disease by enabling early diagnosis at the point of care.”

Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)

Read at BioSpace.com

comments powered by Disqus
Cognoptix
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES